Stock listing

Hanover:2X1 Abivax SA Aktie

German listing (Hanover) of Abivax SA · home listing Euronext:ABVX

Follow Abivax SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:ABVX

€78.95 EUR -3.00 (-3.7%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ABVX

Abivax SA logo
Ticker
Hanover:2X1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Hanover
Currency
EUR

What changed lately

Calls

Replays

  • Abivax (Euronext:ABVX) Q4 2023 Earnings Call

    Mon, Apr 08, 2024 · 8:30 AM ET

    Watch Transcript

Latest news

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Sep 30, 2026

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026

Sep 30, 2026

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26

Sep 25, 2026

Abivax Presents Business Updates and First Half 2026 Financial Results

Sep 21, 2026

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

Jul 30, 2026

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Jul 23, 2026

Abivax Announces Closing of $920 Million Public Offering

Jul 6, 2026

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Jul 2, 2026

Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Jul 1, 2026

Abivax Announces Launch of Public Offering of American Depositary Shares

Jun 30, 2026

All Abivax SA news

Financings

  • Public offering of american Depositary Shares

    Jul 6, 2026

    Closed: US$920M raised · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029

    Closed Jul 6, 2026

Read by 6ix AI from the company's releases

Decks

Abivax SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
28 in the last 12 months · 47 in all · newest Sep 30, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Apr 8, 2024
Decks
16 decks · latest July 2026

Where Abivax SA is listed

ListingExchangeCountryCurrency
Euronext:ABVX · Home listingEuronextFranceEUR
NASDAQ:ABVXNASDAQUnited StatesUSD
LS Exchange:A14UQCLS ExchangeGermanyEUR
gettex:2X1gettexGermanyEUR
LSE:0RA9LSEUnited KingdomEUR
Xetra:2X1XetraGermanyEUR
Tradegate:2X1TradegateGermanyEUR
OTC:AAVXFOTCUnited StatesUSD
Lang & Schwarz:A14UQCLang & SchwarzGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
Frankfurt:2X1FrankfurtGermanyEUR
gettex:2X10gettexGermanyEUR
BX Swiss:ABVXBX SwissSwitzerlandCHF
Dusseldorf:2X1DusseldorfGermanyEUR
Lang & Schwarz:A3EWCPLang & SchwarzGermanyEUR
Munich:2X1MunichGermanyEUR
Hamburg:2X1HamburgGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
BOATS:ABVXBOATSUnited StatesUSD
Frankfurt:2X10FrankfurtGermanyEUR
LS Exchange:A3EWCPLS ExchangeGermanyEUR
Stuttgart:2X1StuttgartGermanyEUR
Turquoise:ABVXPTurquoiseUnited KingdomEUR
VIE:ABVXViennaAustriaEUR
Dusseldorf:2X10DusseldorfGermanyEUR
Hamburg:2X10HamburgGermanyEUR
Munich:2X10MunichGermanyEUR
Stuttgart:2X10StuttgartGermanyEUR
Tradegate:2X10TradegateGermanyEUR
Hanover:2X1 · This pageHanoverGermanyEUR

Log in to ask 6ix AI your own questions about Abivax SA.